The latest financial statement is for the year ending 2025-12-31.
| Cash Flow | 2025-12-31 |
|---|---|
| Net loss | -21,643 |
| Depreciation | 626 |
| Amortization of intangibles | 929 |
| Loss on revaluation of contingent consideration | 2,171 |
| Non-cash lease expense | 1 |
| Stock-based compensation | 9,852 |
| Accounts receivable | 2,023 |
| Inventories | 1,236 |
| Prepaid expenses and other current assets | -1,151 |
| Other assets | 170 |
| Accounts payable | -880 |
| Accrued liabilities | 188 |
| Deferred revenue | -2,638 |
| Other liabilities | -13 |
| Net cash used in operating activities | -13,685 |
| Purchase of property and equipment | 93 |
| Net cash (used in) provided by investing activities | -93 |
| Proceeds from issuance of stock | 15,656 |
| Equity issuance costs | 893 |
| Net cash provided by financing activities | 14,763 |
| Net increase (decrease) in cash, cash equivalents, and restricted cash | 985 |
| Cash, cash equivalents, and restricted cash at beginning of period | 12,436 |
| Cash, cash equivalents, and restricted cash at end of period | 13,421 |
| Cash and cash equivalents | 13,421 |
| Total cash, cash equivalents, and restricted cash | 13,421 |
Stereotaxis, Inc. (STXS)
Stereotaxis, Inc. (STXS)